Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: A microdialysis study

Anesthesia and Analgesia

Volumn 96, Issue 1, 2003, Pages 148-152

  Masuzawa, Munehiro ^a   Nakao, Shinichi ^a   Miyamoto, Etsuko ^a   Yamada, Makiko ^a   Murao, Kouhei ^a   Nishi, Kenichirou ^a   Shingu, Koh ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; KETAMINE; PENTOBARBITAL; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATAXIA; BRAIN PERFUSION; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANESTHETICS, DISSOCIATIVE; ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; ELECTROCHEMISTRY; EXCITATORY AMINO ACID ANTAGONISTS; GABA MODULATORS; KETAMINE; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PENTOBARBITAL; RATS; RATS, WISTAR;

EID: 0037223639     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200301000-00030     Document Type: Article

References (25)

1. Nishizawa N, Nakao S, Nagata A, et al. The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices. Brain Res 2000;857:188-92.
2. White PF, Way WL, Trever AJ. Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36.
3. Lahti AC, Koffel B, LaPorte D, et al. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995;13:9-19.
4. Mattila MA, Larni HM, Nummi SE, Pekkola PO. Effect of diazepam on emergence from ketamine anaesthesia: A double-blind study. Anaesthesist 1979;28:20-3.
5. Magbagbeola JA, Thomas NA. Effect of thiopentone on emergence reactions to ketamine anesthesia. Can J Anaesth 1974;21: 321-4.
6. Spanagel R, Weiss F. The dopamine hypothesis of reward: Past and current status. Trends Neurosci 1999;22:521-7.
7. Roques BP. Novel approaches to targeting neuropeptide systems. Trends Pharmcol Sci 2000;21:475-83.
8. Jin GZ, Zhu ZT, Fu Y. -Stepholidine: A potential novel antipsychotic drug with dual D1 receptor antagonist and D2 receptor antagonist actions. Trends Pharmacol Sci 2002;23:4-7.
9. Mathe JM, Nomikos GG, Schilstrom B, Svensson TH. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res 1998;51:583-92.
10. Weiner AL, Vieira L, McKay CA, Bayer MJ. Ketamine abusers presenting to the emergency department: A case series. J Emerg Med 2000;18:447-51.
11. Ito T, Suzuki T, Wellman SE, et al. Pharmacology of barbiturate tolerance/dependence: GABAA receptors and molecular aspects. Life Sci 1996;59:169-95.
12. Allgulander C. History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatr Scand 1986;73:465-78.
13. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend 1998;51:207-14.
14. Kuhiman JJ Jr, Magluilo J Jr, Levine B, et al. Two deaths involving isoflurane abuse. J Forensic Sci 1993;38:968-71.
15. Spyraki C, Fibiger HC. A role for the mesolimbic dopamine system in the reinforcing properties of diazepam. Psychopharmacology (Berl) 1988;94:133-7.
16. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Ed. San Diego: Academic Press, 1986.
17. Nakao S, Adachi T, Murakawa M, et al. Halothane and diazepam inhibit ketamine-induced c-fos expression in the rat cingulate cortex. Anesthesiology 1996;85:874-82.
18. French ED, Ceci A. Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci Lett 1990;119:159-62.
19. Irifune M, Sato T, Kamata Y, et al. Inhibition by diazepam of ketamine-induced hyperlocomotion and dopamine turnover in mice. Can J Anaesth 1998;45:471-8.
20. Hancock PJ, Stamford JA. Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens. Br J Anaesth 1999;82:603-8.
21. Kimura T, Miyaoka T, Saunders PA, et al. Induction of tolerance to and physical dependence on pentobarbital continuous intracerebroventricular administration. J Pharmacol Exp Ther 1993; 266:1300-5.
22. Invernizzi R, Pozzi L, Samanin R. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats. Neuropharmacology 1991;30: 575-8.
23. Olney JW, Labruyere J, Wang G, et al. NMDA antagonist neurotoxicity: Mechanism and prevention. Science 1991;254: 1515-8.
24. Nakao S, Arai T, Mori K, et al. High-dose ketamine does not induce c-Fos protein expression in rat hippocampus. Neurosci Lett 1993;151:33-6.
25. Nagata A, Nakao S, Miyamoto E, et al. Propofol inhibits ketamine-induced c-fos expression in the rat posterior cingulate cortex. Anesth Analg 1998;87:1416-20.